Results 11 to 20 of about 9,470 (201)
Infantile generalized hypertrichosis caused by topical minoxidil [PDF]
Anais Brasileiros de Dermatologia, 2016 Rare cases of hypertrichosis have been associated with topically applied minoxidil. We present the first reported case in the Brazilian literature of generalized hypertrichosis affecting a 5-year-old child, following use of minoxidil 5%, 20 drops a day ...
Greice Rampon +3 more
doaj +3 more sources
Minoxidil in trichological practice [PDF]
Медицинский совет, 2018 Management of patients with alopecia is still a challenging task. Minoxidil is a pyrimidine derivative, a potent KATP channel opener, and has been shown to act as a vasodilating agent.
O. Yu. Olisova, I. P. Gostroverkhova
doaj +2 more sources
Pharmacological correction of retinal ischemia/reperfusion by minoxidil [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2018 Introduction/Objective. The objective of this paper was to increase the effectiveness of pharmacological correction of retinal ischemia-reperfusion by using minoxidil. Methods. The research was carried out on 180 Wistar rats.
Peresypkina Anna A. +4 more
doaj +4 more sources
Characterization of Soluplus/ASC-DP Nanoparticles Encapsulated with Minoxidil for Skin Targeting
ChemEngineering, 2021 Soluplus (Sol) is an amphiphilic graft copolymer capable of forming self-assembled micelles and L-ascorbyl 2,6-dipalmitate (ASC-DP) aggregates spontaneously to form micelles.
Rina Takayama +4 more
doaj +2 more sources
Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation
Acta Dermato-VenereologicaTopical minoxidil is the mainstay of treatment for androgenic alopecia and is also used off-label for other forms of hair loss. Despite its efficacy and favourable safety profile, the use of minoxidil is associated with various side effects, the most ...
Alexandra Junge +7 more
doaj +2 more sources
Drug Design, Development and Therapy, 2013 Farouk M Sakr,1 Ali MI Gado,2 Haseebur R Mohammed,2 Abdel Nasser Ismail Adam3 1Department of Pharmaceutics, 2Departments of Pharmacology and Pharmaceutical Chemistry, 3Department of Biology, College of Pharmacy, Riyadh Colleges of Dentistry and Pharmacy,
Sakr FM, Gado AMI, Mohammed HR, Adam ANI
doaj +1 more source
Southern Medical Journal, 1980 Minoxidil (U-10,858) has been shown in several controlled and blind studies and numerous uncontrolled studies to be a potent peripheral vasodilator for use in the management of sustained, severe, accelerating or malignant hypertension and moderate hypertension inadequately controlled by conventional therapy.
+6 more sources
Novel “After Minoxidil” spray improves topical minoxidil compliance and hair style manageability [PDF]
, 2020 BACKGROUND: Topical minoxidil is the only US FDA-approved drug for the treatment of female pattern hair loss (FPHL). While the safety profile of topical minoxidil is excellent, the efficacy of minoxidil in hair growth is extremely low. A recent survey of
Mirna Situm +23 more
core +1 more source
Minoxidil: a comprehensive review
, 2021 Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women. Mechanism of action: Minoxidil acts through multiple pathways (vasodilator, anti-inflammatory agent, inducer of the Wnt/β-catenin ...
M. Venkataraman +3 more
core +1 more source
Oral Minoxidil for Androgenetic Alopecia
, 2022 Purpose: The purpose of this article is to review the current treatment options of androgenetic alopecia and to explore the risk and potential benefits of oral Minoxidil therapy.
Ingram, Laurice D
core +1 more source